DR. DAVID KEMBLE
NPI 1396503041
Pathology - Chemical Pathology in Boston, MA
NPI Status: Active since March 07, 2024
Contact Information
330 BROOKLINE AVE # 308
BOSTON, MA
ZIP 02215
Phone: (617) 667-0456
- Individual
- Male
- Pathology
- Chemical Pathology
About DAVID KEMBLE
This page provides the complete NPI Profile along with additional information for David Kemble, a provider established in Boston, Massachusetts with a medical specialization in Pathology, focusing in chemical pathology . The healthcare provider is registered in the NPI registry with number 1396503041 assigned on March 2024. The practitioner's primary taxonomy code is 207ZP0104X with license number 1272 (DE). The provider is registered as an individual and his NPI record was last updated 2 years ago.
- NPI
- 1396503041
- Provider Name
- DR. DAVID KEMBLE
- Gender
- Male
- Entity Type
- Individual
- Location Address
- 330 BROOKLINE AVE # 308 BOSTON, MA 02215
- Location Phone
- (617) 667-0456
- Mailing Address
- 330 BROOKLINE AVE # 308 BOSTON, MA 02215
- Is Sole Proprietor?
- No
- Enumeration Date
- 03-07-2024
- Last Update Date
- 03-07-2024
- Code Navigator
Location Map
Specialty - Primary Taxonomy
The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.
- Classification
Pathology Chemical Pathology
- Taxonomy Code
- 207ZP0104X
- Type
- Allopathic & Osteopathic Physicians
- License No.
- 1272
- License State
- DE
- Taxonomy Description
- A chemical pathologist has expertise in the biochemistry of the human body as it applies to the understanding of the cause and progress of disease. This physician functions as a clinical consultant in the diagnosis and treatment of human disease. Chemical pathology entails the application of biochemical data to the detection, confirmation or monitoring of disease.
Reviews for DR. DAVID KEMBLE
There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.
NPI NPI Number Validation
How NPI Validation Works
The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.
To verify the NPI 1396503041, we treat the final digit (1) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 59. The final step is to find the difference between that total and the next multiple of ten (60 - 59 = 1).
Digit-by-digit view
Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.
Step 1: Double every other digit from the right
Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.
Step 2: Add all digits plus the NPI constant
Add the transformed values, the unchanged digits, and the constant 24.
Step 3: Find the amount needed to reach the next multiple of 10
The next multiple of ten after 59 is 60. The difference is the calculated check digit.
Frequently Asked Questions
The NPI number assigned to this healthcare provider is 1396503041, enumerated as an "individual" on March 07, 2024.
The provider is located at 330 BROOKLINE AVE # 308 BOSTON, MA 02215 and the phone number is (617) 667-0456.
Pathology with taxonomy code 207ZP0104X and a focus in Chemical Pathology.
